At UCHealth the use of pharmacogenetics when prescribing rosuvastatin will occur in patients who meet the following conditions:
1) Provided a blood or saliva sample to the Colorado Center for Personalized Medicine (CCPM) Biobank laboratory and this sample has undergone genotyping.
2) Have consented for return of their results.
3) Are prescribed rosuvastatin.
This process takes a minimum of 4-6 weeks but may take several years. Therefore, results will not be available at initial presentation if a patient has not previously enrolled in the Biobank.
If you are a provider AND your patient has SLCO1B1 decreased or poor function and/or ABCG2 poor function genetic variants, an inline medication warning will appear if you attempt to prescribe rosuvastatin. If the inline medication warning is visible, links to resources will be listed for your reference.